123 related articles for article (PubMed ID: 38721683)
1. The performance and costs of XTT, resazurin, MTS and luciferin as viability dyes in in vitro susceptibility testing of Madurella mycetomatis.
Ma J; Eadie K; Fahal A; Verbon A; van de Sande WWJ
Trans R Soc Trop Med Hyg; 2024 May; ():. PubMed ID: 38721683
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an
Abd Algaffar SO; Verbon A; van de Sande WWJ; Khalid SA
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318015
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5- sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay.
Ahmed AO; van de Sande WW; van Vianen W; van Belkum A; Fahal AH; Verbrugh HA; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2004 Jul; 48(7):2742-6. PubMed ID: 15215141
[TBL] [Abstract][Full Text] [Related]
4. Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.
van de Sande WW; Luijendijk A; Ahmed AO; Bakker-Woudenberg IA; van Belkum A
Antimicrob Agents Chemother; 2005 Apr; 49(4):1364-8. PubMed ID: 15793113
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Disc Diffusion, Etest, and a Modified CLSI Broth Microdilution Method for
Nyuykonge B; van Amelsvoort L; Eadie K; Fahal AH; Verbon A; van de Sande W
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0043321. PubMed ID: 34181477
[TBL] [Abstract][Full Text] [Related]
6. The combination of manogepix and itraconazole is synergistic and inhibits the growth of Madurella mycetomatis in vitro but not in vivo.
Konings M; Eadie K; Strepis N; Nyuykonge B; Fahal AH; Verbon A; van de Sande WWJ
Med Mycol; 2023 Nov; 61(11):. PubMed ID: 37960934
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
Nyuykonge B; Siddig EE; Mhmoud NA; Nyaoke BA; Zijlstra EE; Verbon A; Bakhiet S; Fahal AH; van de Sande WWJ
Mycoses; 2022 Dec; 65(12):1170-1178. PubMed ID: 36005544
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic implications of mycetoma derived from Madurella pseudomycetomatis isolates from Mexico.
Nyuykonge B; Klaassen CHW; Zandijk WHA; de Hoog GS; Ahmed SA; Desnos-Ollivier M; Verbon A; Bonifaz A; van de Sande WWJ
J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1828-1834. PubMed ID: 32233084
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in Madurella mycetomatis infected Galleria mellonella.
Lim W; Konings M; Parel F; Eadie K; Strepis N; Fahal A; Verbon A; van de Sande WWJ
Med Mycol; 2022 Feb; 60(2):. PubMed ID: 35064672
[TBL] [Abstract][Full Text] [Related]
10. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole.
van de Sande WW; de Kat J; Coppens J; Ahmed AO; Fahal A; Verbrugh H; van Belkum A
Microbes Infect; 2007 Jul; 9(9):1114-23. PubMed ID: 17644456
[TBL] [Abstract][Full Text] [Related]
11. Pyomelanin Secretion in Madurella mycetomatis Interferes with Spectrophotometric Endpoint Reading Using the Sensititre YeastOne alamarBlue Assay but Not with Visual Endpoint Reading.
Nyuykonge B; Croughs PD; Fahal AH; Verbon A; van de Sande WWJ
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611353
[TBL] [Abstract][Full Text] [Related]
12. Madurella mycetomatis, the main causative agent of eumycetoma, is highly susceptible to olorofim.
Lim W; Eadie K; Konings M; Rijnders B; Fahal AH; Oliver JD; Birch M; Verbon A; van de Sande W
J Antimicrob Chemother; 2020 Apr; 75(4):936-941. PubMed ID: 31904836
[TBL] [Abstract][Full Text] [Related]
13. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
Meletiadis J; Mouton JW; Meis JF; Bouman BA; Donnelly PJ; Verweij PE;
J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
[TBL] [Abstract][Full Text] [Related]
14. Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis.
Eadie K; Parel F; Helvert-van Poppel M; Fahal A; van de Sande W
Trop Med Int Health; 2017 Jun; 22(6):696-702. PubMed ID: 28342219
[TBL] [Abstract][Full Text] [Related]
15. The synthetic synergistic cinnamon oil CIN-102 is active against Madurella mycetomatis, the most common causative agent of mycetoma.
Konings M; Eadie K; Lim W; Fahal AH; Mouton J; Tesse N; van de Sande WWJ
PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009488. PubMed ID: 34106933
[TBL] [Abstract][Full Text] [Related]
16. VNTR confirms the heterogeneity of Madurella mycetomatis and is a promising typing tool for this mycetoma causing agent.
Lim W; Eadie K; Horst-Kreft D; Ahmed SA; Fahal AH; van de Sande WWJ
Med Mycol; 2019 Jun; 57(4):434-440. PubMed ID: 30085253
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Madurella mycetomatis to posaconazole and terbinafine.
van Belkum A; Fahal AH; van de Sande WW
Antimicrob Agents Chemother; 2011 Apr; 55(4):1771-3. PubMed ID: 21263050
[TBL] [Abstract][Full Text] [Related]
18. The development of a novel diagnostic PCR for Madurella mycetomatis using a comparative genome approach.
Lim W; Siddig E; Eadie K; Nyuykonge B; Ahmed S; Fahal A; Verbon A; Smit S; van de Sande WW
PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008897. PubMed ID: 33326425
[TBL] [Abstract][Full Text] [Related]
19. A Madurella mycetomatis Grain Model in Galleria mellonella Larvae.
Kloezen W; van Helvert-van Poppel M; Fahal AH; van de Sande WW
PLoS Negl Trop Dis; 2015; 9(7):e0003926. PubMed ID: 26173126
[TBL] [Abstract][Full Text] [Related]
20. Use of immunoblotting in testing Madurella mycetomatis specific antigen.
ELbadawi HS; Mahgoub E; Mahmoud N; Fahal AH
Trans R Soc Trop Med Hyg; 2016 May; 110(5):312-6. PubMed ID: 27198216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]